2004 Fiscal Year Final Research Report Summary
Involvement of ganglioside in lifestyle-related disease and cancer, and the development of new diagnostic method and therapeutic strategy
Project/Area Number |
15390019
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Biological pharmacy
|
Research Institution | HOKKAIDO UNIVERSITY |
Principal Investigator |
INOKUCHI Jun-ichi Hokkaido Univ., Grad.School of Pharm., Asso.Prof., 大学院・薬学研究科, 助教授 (70131810)
|
Co-Investigator(Kenkyū-buntansha) |
IGARASHI Yasuyuki Hokkaido Univ., Grad.School of Pharm., Prof., 大学院・薬学研究科, 教授 (70091965)
|
Project Period (FY) |
2003 – 2004
|
Keywords | lifestyle-related disease / type 2 diabetes / ganalioside / Insulin resistance / microdomain / adioocyte / TNFα |
Research Abstract |
Membrane microdomains (lipid rafts) are now recognized as critical for proper compartmentalization of insulin signaling, but their role in the pathogenesis of insulin resistance has not been investigated. Detergent-resistant membrane microdomains (DRMs), isolated in the low density fractions, are highly enriched in cholesterol, glycosphingolipids and various signaling molecules. TNFα induces insulin resistance in type 2 diabetes, but its mechanism of action is not fully understood. We have found a selective increase in the acidic glycosphingolipid ganglioside GM3 in 3T3-L1 adipocytes treated with TNFα, suggesting a specific function for GM3. In the DRMs from TNFα-treated 3T3-L1 adipocytes, GM3 levels were doubled compared with results in normal adipocytes. Additionally, insulin receptor (IR) accumulations in the DRMs were diminished, while caveolin and flotillin levels were unchanged. Furthermore, insulin-dependent IR internalization and intracellular movement of the IR substrate 1(IRS-1) were both greatly suppressed in the treated cells, leading to an uncoupling of IR-IRS-1 signaling. GM3 depletion was able to counteract the TNFα-induced inhibitions of IR internalization and accumulation into DRMs. Together, these findings provide compelling evidence that in insulin resistance the insulin metabolic signaling defect can be attributed to a loss of IRs in the microdomains due to an accumulation of GM3.
|
Research Products
(11 results)